World's Best Scientists 2026 revealed!
Richard G. Vile

Richard G. Vile

D-Index & Metrics

Microbiology

D-Index
90
Citations
23819
World Ranking
701
National Ranking
325

Medicine

D-Index
91
Citations
24276
World Ranking
11928
National Ranking
6118

Richard G. Vile publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Richard G. Vile sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 362 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Richard G. Vile D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard G. Vile sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 90 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Richard G. Vile is affiliated with the Mayo Clinic in the United States. Their research work primarily spans across the fields of Biochemistry, Genetics and Molecular Biology; Medicine; and Immunology and Microbiology. Within these principal fields of study, several subfields are prominently represented, including Genetics, Immunology, Oncology, Molecular Biology, and Infectious Diseases.

The main topics of Richard G. Vile's research include virus-based gene therapy, CAR-T cell therapy, immunotherapy and immune responses, viral infectious diseases and gene expression in insects, cancer research and treatments, interferon and immune responses, as well as immune cell function and interaction.

Among their recent publications are:

  • "Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice," 2022, Science Translational Medicine
  • "Oncolytic virotherapy as immunotherapy," 2021, Science
  • "Oncolytic virus-derived type I interferon restricts CAR T cell therapy," 2020, Nature Communications
  • "Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators," 2020, Brain
  • "APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy," 2020, Nature Communications

Frequent co-authors in their research include Alan Melcher, Laura Evgin, Jason M. Tonne, Jill Thompson, and Kevin J. Harrington.

Their research has been published regularly in several venues, notably:

  • Nature Communications
  • The Journal of Immunology
  • Molecular Therapy - Oncolytics
  • Neuro-Oncology
  • Journal for ImmunoTherapy of Cancer

Best Publications

  • Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.

    Kevin J. Harrington;Kevin J. Harrington;Sima Mohammadtaghi;Paul S. Uster;Daphne Glass

  • Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood

    Rajiv Gulati;Dragan Jevremovic;Timothy E. Peterson;Suvro Chatterjee

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

    Alan Melcher;Stephen Todryk;Nicola Hardwick;Martin Ford

  • Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake.

    Stephen Todryk;Alan A. Melcher;Alan A. Melcher;Nicola Hardwick;Emmanouela Linardakis

  • Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

    Adel Samson;Karen J. Scott;David Taggart;Emma J. West

  • Use of Tissue-specific Expression of the Herpes Simplex Virus Thymidine Kinase Gene to Inhibit Growth of Established Murine Melanomas following Direct Intratumoral Injection of DNA

    Richard G. Vile;Ian R. Hart

  • Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus.

    Rosa Maria Diaz;Feorillo Galivo;Timothy Kottke;Phonphimon Wongthida

  • Cancer gene therapy: hard lessons and new courses.

    R G Vile;S J Russell;N R Lemoine

  • In Vitro and in Vivo Targeting of Gene Expression to Melanoma Cells

    Richard G. Vile;Ian R. Hart

  • A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer.

    Laura Vidal;Hardev S. Pandha;Timothy A. Yap;Christine L. White

  • Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice.

    Deanna Grote;Stephen J. Russell;Stephen J. Russell;Tatjana I. Cornu;Tatjana I. Cornu;Roberto Cattaneo;Roberto Cattaneo

  • Generation of an anti‐tumour immune response in a non‐immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1‐like profile of intratumoural cytokine expression

    Richard G. Vile;Simon Castleden;John Marshall;Richard Camplejohn

  • The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon

    Robin J. Prestwich;Fiona Errington;Rosa M. Diaz;Hardev S. Pandha

  • Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication

    Robin J. Prestwich;Elizabeth J. Ilett;Fiona Errington;Rosa M. Diaz

  • Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity

    Fiona Errington;Lynette Steele;Robin Prestwich;Kevin J. Harrington

  • Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer.

    Kevin J Harrington;C R Lewanski;A D Northcote;J Whittaker

  • Oncolytic viruses: a novel form of immunotherapy

    Robin J.D. Prestwich;Kevin J. Harrington;Hardev S. Pandha;Richard G. Vile

  • Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity

    Robin J. Prestwich;Fiona Errington;Elizabeth J. Ilett;Ruth S.M. Morgan

  • Autologous Culture-Modified Mononuclear Cells Confer Vascular Protection After Arterial Injury

    Rajiv Gulati;Dragan Jevremovic;Timothy E. Peterson;Tyra A. Witt

  • Strategies for antigen loading of dendritic cells to enhance the antitumor immune response.

    Scott E. Strome;Stephen Voss;Ryan Wilcox;Tamekia L. Wakefield

Frequent Co-Authors

Alan Melcher
Alan Melcher Institute of Cancer Research
Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
Timothy Kottke
Timothy Kottke Mayo Clinic
Peter Selby
Peter Selby University of Leeds
Matthew C. Coffey
Matthew C. Coffey Oncolytics Biotech (Canada)
Michael J. Gough
Michael J. Gough Providence Portland Medical Center
Atique U. Ahmed
Atique U. Ahmed Northwestern University
Glen N. Barber
Glen N. Barber University of Miami
Stephen Todryk
Stephen Todryk Northumbria University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their education beyond microbiology, pursuing accredited online mph programs easy to get into offers a flexible route to specializing in public health fields. These programs are ideal for students seeking accessible options to advance their careers without compromising quality.

Certain career paths, such as becoming a child life specialist salary with bachelor degree, highlight how a microbiology background combined with specialized training can lead to rewarding roles in healthcare settings, focusing on pediatric support and therapeutic communication.

For individuals with unique circumstances, including those with prior convictions, exploring the best associate degrees for felons can open educational doors and offer new career possibilities in fields related to microbiology, such as lab tech or healthcare support roles.

Another promising pathway is becoming a functional medicine nurse practitioner. This role integrates holistic approaches with scientific knowledge, where expertise in microbiology can greatly enhance understanding of disease mechanisms and patient care strategies.

Best Scientists Citing Richard G. Vile

Trending Scientists

Recently Published Articles